Primmune Therapeutics

1 follower

‌

Primmune Therapeutics is developing an orally administered TLR7 agonist to stimulate innate immunity in cancer immunotherapy. Their goal is to improve the response rate of patients to current and future immunotherapy medicines.

Industries

Headquarters

Employees

Links

Org chart

Charles McDermott

Chairman, President & CEO

Charles McDermott

Collapse

Richard Daniels

Chief Operating Officer

Paulo Rangel

Chief Business Officer & Co-Founder

James Appleman

SVP, R&D & CSO Co-Founder, Director

Curtis Scribner

Chief Medical Officer

Scott Zook

Senior Vice President Global Manufacturing

Stephen E. Webber

VP, Medicinal Chemistry, & Co-Founder

Randy Adams

Senior Advisor Commercial Strategy

Teams

Leadership Team

6 members

Clinical Advisors Team

4 members

Legal and Governance Team

3 members

Research and Development Team

3 members

Similar companies

Thermo Fisher Scientific

141 followers

Regeneron

88 followers

Vertex Pharmaceuticals

50 followers

Verily Life Sciences

36 followers

Alexion Pharmaceuticals

32 followers

PerkinElmer

8 followers

Merck

195 followers

AbbVie

151 followers

CytomX

3 followers

Aldevron

2 followers

Worldwide Clinical Trials

4 followers

Discover companies